openPR Logo
Press release

Advanced Genomics and Transcriptomics Sequencing Services Market to Reach USD 1,740.1 Million by 2036, Fueled by Outsourced Research Workflows and Precision Medicine Demand

07-23-2026 05:44 AM CET | Health & Medicine

Press release from: Fact.MR

Advanced Genomics and Transcriptomics Sequencing Services Market

Advanced Genomics and Transcriptomics Sequencing Services Market

The global Advanced Genomics and Transcriptomics Sequencing Services Market is projected to grow from USD 721.7 million in 2026 to USD 1,740.1 million by 2036, registering a 9.2% CAGR during the 2026-2036 forecast period. The market surpassed USD 660.9 million in 2025 and is expected to create an absolute opportunity of USD 1,018.4 million as pharmaceutical companies, academic institutions, hospitals, and contract research organizations increasingly outsource sequencing, bioinformatics, and scientific reporting activities.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15613

Key Market Highlights at a Glance

• Market value in 2026: USD 721.7 million
• Market value in 2036: USD 1,740.1 million
• CAGR (2026-2036): 9.2%

• Absolute opportunity by 2036: USD 1,018.4 million
• Leading Service Type: Whole Genome Sequencing, 25.0% share
• Leading Technology: Next-Generation Sequencing (NGS), 25.0% share
• Leading Application: Biomarker Discovery, 25.0% share
• Leading End User: Pharmaceutical & Biotechnology Companies, 30.0% share
• Fastest-growing country: Germany, 12.4% CAGR

Why Is the Advanced Genomics and Transcriptomics Sequencing Services Market Growing?

Key demand drivers include:

• Expansion of population-scale genome programs requiring sequencing, data management, and interpretation services.
• Rising adoption of long-read sequencing and full-length RNA analysis for structural variant and methylation studies.
• Increasing use of single-cell, spatial transcriptomics, and biomarker discovery programs across drug development.

"Competition in advanced genomics and transcriptomics services now depends more on clear and reliable results than on access to sequencing alone. Providers that combine study planning, sample-quality management, testing, and scientific reporting are positioned to gain broader adoption," said Shambhu Nath Jha, Senior Analyst, Fact.MR.

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/15613

Which Service Type Leads Market Share?
Whole Genome Sequencing is expected to hold 25.0% of service demand in 2026. Researchers favor this approach because it enables comprehensive detection of single-nucleotide variants, copy-number changes, and structural variants through one workflow.

Key service insights:
• Whole Genome Sequencing share: 25.0%
• Supported by rare-disease and population genomics projects
• Benefiting from expanding genome reference initiatives

Why Does NGS Dominate Technology Adoption?
Next-Generation Sequencing (NGS) is projected to account for 25.0% of technology demand in 2026. Its established workflow ecosystem supports genome, exome, panel, and transcriptome sequencing services at scale.

Technology highlights:

• NGS share: 25.0%
• Widely used across genomics and transcriptomics workflows
• Enables repeatable throughput and standardized analysis

Gain Full Access to Market Forecasts and Key Drivers: https://www.factmr.com/report/advanced-genomics-and-transcriptomics-sequencing-services-market

Which Applications and End Users Drive Demand?
Biomarker Discovery is anticipated to represent 25.0% of application revenue because it connects genomic insights with disease mechanisms and therapeutic targets.

Application and end-user highlights:
• Biomarker Discovery share: 25.0%
• Pharmaceutical & Biotechnology Companies share: 30.0%
• Strong demand from target discovery, cohort design, and translational research

Market Dynamics

Drivers
• Population-scale genome reference programs
• Long-read structural and isoform characterization
• Single-cell and spatial transcriptomic mapping
• Multi-omics integration initiatives
• Pharmaceutical biomarker research demand

Restraints
• Batch effects and reproducibility challenges
• Limited sample availability in complex studies
• Regulatory chain-of-custody requirements
• Bioinformatics staffing and infrastructure gaps

Trends
• Multi-omics integration platforms
• Federated data interoperability frameworks
• Precision-medicine panel development
• Clinical-grade sequencing service certification

Regional and Country Outlook

Country growth rates:

• Germany: 12.4% CAGR
• Brazil: 11.5% CAGR
• USA: 10.6% CAGR
• South Korea: 9.7% CAGR
• United Kingdom: 8.7% CAGR
• Japan: 7.8% CAGR

Germany leads growth through genome programs, university hospital networks, and secure cross-border research collaboration. Brazil benefits from population diversity and growing demand for long-read sequencing services.

The United States gains momentum from large-scale single-cell and tissue-mapping initiatives. South Korea is supported by hospital-led multi-omics research and reproducibility-focused workflows.

The United Kingdom advances through biomarker research and established genomics infrastructure, while Japan's growth is linked to stringent sample tracking, governance, and quality standards.

Competitive Landscape

Key market participants include:

• Illumina, Inc. - High-throughput short-read sequencing leadership
• Eurofins Scientific SE - Global laboratory services network
• Revvity, Inc. - Advanced life-science research solutions
• PacBio - Highly accurate long-read sequencing systems
• Oxford Nanopore Technologies plc - Real-time DNA and RNA sequencing
• Azenta Life Sciences - Sample management and sequencing support
• BGI Genomics Co., Ltd. - Large-scale genomics capabilities
• Novogene Co., Ltd. - End-to-end sequencing service provider

Competition is increasingly centered on sample quality control, integrated bioinformatics, workflow standardization, and scientifically actionable reporting rather than sequencing access alone.

Discover the Latest Insights in the Healthcare Industry: https://www.factmr.com/industry/healthcare

FAQ

What is the Advanced Genomics and Transcriptomics Sequencing Services Market size by 2036?
The market is forecast to reach USD 1,740.1 million by 2036.

What is the expected CAGR?
The market is projected to grow at a 9.2% CAGR from 2026 to 2036.

Which service segment leads the market?
Whole Genome Sequencing leads with a 25.0% market share in 2026.

Which technology dominates adoption?
Next-Generation Sequencing (NGS) accounts for 25.0% of technology demand in 2026.

Which application holds the largest share?
Biomarker Discovery leads applications with a 25.0% share.

Which end-user segment is largest?
Pharmaceutical & Biotechnology Companies represent 30.0% of demand in 2026.

Which country is growing fastest?
Germany is the fastest-growing major market with a 12.4% CAGR through 2036.

Top Trending Reports:
Advanced Bipolar Direct Energy Devices Market: https://www.factmr.com/report/advanced-bipolar-direct-energy-devices-market
Advanced Parenteral Drug Market: https://www.factmr.com/report/advanced-parenteral-drug-market
Advanced Ophthalmology Technologies Market https://www.factmr.com/report/advanced-ophthalmology-technologies-market
Advanced Wound Dressing Market: https://www.factmr.com/report/advanced-wound-dressing-market

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advanced Genomics and Transcriptomics Sequencing Services Market to Reach USD 1,740.1 Million by 2036, Fueled by Outsourced Research Workflows and Precision Medicine Demand here

News-ID: 4584263 • Views:

More Releases from Fact.MR

Hybrid Marine Capstans Market is Forecast to Record a 7.8% CAGR from 2026 to 2036 | DMT Marine Equipment, Markey Machinery, MacGregor
Hybrid Marine Capstans Market is Forecast to Record a 7.8% CAGR from 2026 to 203 …
The global Hybrid Marine Capstans Market is witnessing steady growth as maritime operators increasingly modernize vessel deck machinery with hybrid-powered capstans that deliver greater operational control, energy efficiency, and safety. According to Fact.MR, the market, which surpassed USD 129.9 million in 2025, is expected to grow from USD 140 million in 2026 to USD 296.7 million by 2036, registering a healthy 7.8% CAGR during the forecast period. Get Detailed Market Forecasts,
Synthetic Driving Scenarios Market is Growing at a 20.5% CAGR by 2036 | NVIDIA, Applied Intuition, Foretellix, Synopsys, dSPACE
Synthetic Driving Scenarios Market is Growing at a 20.5% CAGR by 2036 | NVIDIA, …
The global Synthetic Driving Scenarios Market is entering a phase of rapid expansion as automotive OEMs, autonomous vehicle developers, and advanced driver assistance system (ADAS) suppliers increasingly adopt simulation-driven validation platforms to improve safety, reduce testing costs, and accelerate software development. According to Fact.MR, the market is estimated at USD 0.6 billion in 2026 and is forecast to reach USD 3.9 billion by 2036, registering an impressive 20.5% CAGR during
Demand for Automotive Composites in USA Is Forecast to Expand USD 7.32 Billion By 2036 | Toray Industries Incorporated, SGL Carbon SE, Hexcel, Mitsubishi Chemical
Demand for Automotive Composites in USA Is Forecast to Expand USD 7.32 Billion B …
The United States automotive composites market continues to gain momentum as automakers accelerate the transition toward lightweight, fuel-efficient, and electrified vehicles. According to Fact.MR, demand for automotive composites in the U.S. was valued at USD 3.66 billion in 2025 and is projected to increase from USD 3.90 billion in 2026 to USD 7.32 billion by 2036, registering a CAGR of 6.5% during the forecast period. Get Detailed Market Forecasts, Competitive Benchmarking,
USA Heavy Equipment Lamps Market Valued USD 1.32 billion in 2026 Driven by HELLA KGaA Hueck & Co, Truck-Lite Co. LLC, Peterson Manufacturing Company, Grote Industries, Federal-Mogul Corporation & Valeo
USA Heavy Equipment Lamps Market Valued USD 1.32 billion in 2026 Driven by HELLA …
The U.S. Heavy Equipment Lamps Market is projected to grow from USD 1.32 billion in 2026 to USD 1.55 billion by 2036, registering a CAGR of 1.6% during the forecast period, according to Fact.MR. The market was valued at USD 1.30 billion in 2025, reflecting the stable demand generated by the country's large installed base of construction, mining, agriculture, forestry, and industrial equipment. Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing

All 5 Releases


More Releases for Sequencing

Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period. Market Outlook: The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: Baseclear B.V. Clinical-Microbiomics A/S Molzym GmbH & Co. Kg Zymo Research Corp. Rancho Biosciences Microbiome Therapeutics, LLC. Microbiome Insights Inc. Openbiome Resphera Biosciences, LLC. Ubiome, Inc. The report covers key developments
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com Get Research Sample PDF at https://www.search4research.com/request-sample/113582/ Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period. Metagenomics, is a field where genomic analysis of microbial DNA